Kukje Pharma Co., Ltd. (002720.KS)
002720.KS Stock Price Chart
Explore Kukje Pharma Co., Ltd. interactive price chart. Choose custom timeframes to analyze 002720.KS price movements and trends.
002720.KS Company Profile
Discover essential business fundamentals and corporate details for Kukje Pharma Co., Ltd. (002720.KS) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
29 Sept 2005
Employees
242.00
Website
https://www.kukjepharm.co.krCEO
Tae-hoon Nam
Description
Kukje Pharma Co., Ltd. engages in manufacturing, importing, exporting, selling, and distributing pharmaceutical products. The company offers pharmaceutical products, including ETC and OTC products, raw materials, intermediates, and side chain products, as well as cosmetics and health care products. Its products include cephalosporins, quinolones, tetracycline, aminoglycosides, macrolides, ophthalmic, antifungal and antiviral agents, ophthalmic agents, adrenal corticosteroids, CNS and osteoporotic agents, antihistamines, NSAIDS and other analgesics, gastrointestinal and cardiovascular agents, antidiabetics, genitourinary and respiratory agents, and other ETC products. The company was founded in 1959 and is headquartered in Seongnam, South Korea.
002720.KS Financial Timeline
Browse a chronological timeline of Kukje Pharma Co., Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Dividend declared on 13 Mar 2025
A dividend of ₩30.00 per share was announced, adjusted to ₩30.00. The dividend was paid on 21 Apr 2025.
Earnings released on 31 Dec 2024
EPS came in at ₩34.76 , while revenue for the quarter reached ₩41.64B .
Earnings released on 30 Sept 2024
EPS came in at ₩57.00 , while revenue for the quarter reached ₩39.65B .
Earnings released on 29 Jun 2024
EPS came in at ₩29.34 , while revenue for the quarter reached ₩37.64B .
Earnings released on 30 Mar 2024
EPS came in at ₩135.04 , while revenue for the quarter reached ₩37.53B .
Earnings released on 30 Dec 2023
EPS came in at -₩19.22 , while revenue for the quarter reached ₩35.30B .
Earnings released on 30 Sept 2023
EPS came in at -₩128.08 , while revenue for the quarter reached ₩32.12B .
Earnings released on 30 Jun 2023
EPS came in at -₩309.37 , while revenue for the quarter reached ₩35.54B .
Earnings released on 31 Mar 2023
EPS came in at ₩43.19 , while revenue for the quarter reached ₩32.41B .
Stock split effective on 17 Mar 2023
Shares were split 21 : 20 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 31 Dec 2022
EPS came in at -₩61.02 , while revenue for the quarter reached ₩30.93B .
Earnings released on 30 Sept 2022
EPS came in at ₩71.91 , while revenue for the quarter reached ₩30.16B .
Earnings released on 30 Jun 2022
EPS came in at ₩58.60 , while revenue for the quarter reached ₩32.24B .
Earnings released on 31 Mar 2022
EPS came in at ₩111.22 , while revenue for the quarter reached ₩33.25B .
Stock split effective on 18 Mar 2022
Shares were split 21 : 20 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 31 Dec 2021
EPS came in at -₩182.52 , while revenue for the quarter reached ₩32.90B .
Earnings released on 30 Sept 2021
EPS came in at ₩38.10 , while revenue for the quarter reached ₩29.83B .
Earnings released on 30 Jun 2021
EPS came in at ₩6.35 , while revenue for the quarter reached ₩29.63B .
Earnings released on 31 Mar 2021
EPS came in at ₩41.72 , while revenue for the quarter reached ₩27.38B .
Stock split effective on 2 Mar 2021
Shares were split 21 : 20 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 31 Dec 2020
EPS came in at -₩199.47 , while revenue for the quarter reached ₩28.25B .
Earnings released on 30 Sept 2020
EPS came in at ₩31.10 , while revenue for the quarter reached ₩33.49B .
002720.KS Stock Performance
Access detailed 002720.KS performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.